Events
Nanoparticles in Therapeutic Innovation
Friday 19 September 2025 - Amsterdam






Thrilled to have joined the 6th MELOMANES MSCA project meeting in Amsterdam at Athena Research and Education Institute. These meetings provide a valuable platform to deepen collaborations and foster dynamic exchanges of perspectives.
We have the chance to benefit from the collective expertise of all partners. We’re inspired by the remarkable progress achieved so far and to look forward with confidence to the next steps of this collaborative journey!


We were delighted to attend the 2025 Innovative Therapies Days, a landmark event connecting academia and industry, from research and proof of concept to clinical and industrial translation. By offering an exceptional insight into the evolving landscape of advanced therapeutic development, highlighting breakthroughs in cell and gene therapies, CAR-T innovation, and particularly the emerging role of extracellular vesicles (EVs) as next-generation therapeutic platforms, these perspectives align with Exosiris’s mission to drive precise, personalized treatments for unmet clinical needs.


Exosiris was present at the PSCC Innovation Forum 2026
February 4th 2026 - Villejuif
We were proud to be present at the PSCC Innovation Forum 2026, where more than 700 participants gathered on World Cancer Day to advance innovation in oncology. The event brought together entrepreneurs, researchers, investors, industry leaders, large companies, patients, and patient associations, highlighting the strength and collaboration of the oncology ecosystem. With 30 world-class speakers, over 650 B2B meetings, and inspiring startup pitches, the forum showcased cutting-edge breakthroughs and the collective momentum driving the future of cancer innovation.
Upcoming Event: MELOMANES Consortium Meeting
& Training Sessions
March 16th to 20th 2026 - in Cambridge


International Symposium: Innovative Therapies Days
October 9th & 10th, 2025 - Kursaal Besançon
Publications
Newsletter
Stay updated on groundbreaking nanomedicine advancements.
